Internal Medicine, Rheumatology · St Petersburg, FL
NPI
1720287659
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
620 10th St N
St Petersburg, FL, 33705
Phone (727) 824-8325
Groups this clinician bills Medicare through
Medicare paid, 2024
$438K
34,480 services
Medicare patients, 2024
441
Average age 74
Drug cost, 2024
$2.1M
1,978 prescriptions
Company payments, 2025
$4,098
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abie A Samuel was code J0897 (injection, denosumab, 1 mg), 12,720 times for 136 patients. In total Abie A Samuel billed 34,480 services in 14 codes, and Medicare paid $438K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 12,720 | 136 | $20.48 | $261K |
| 99214 Office E&M - Established | Office | 843 | 394 | $87.58 | $74K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 586 | 296 | $11.61 | $6,805 |
| 96372 Injection Administration | Office | 188 | 87 | $10.76 | $2,024 |
| 96401 Chemotherapy Administration | Office | 134 | 115 | $47.24 | $6,330 |
| 99213 Office E&M - Established | Office | 62 | 54 | $55.50 | $3,441 |
| 99204 Office E&M - New | Office | 57 | 57 | $110.16 | $6,279 |
| 99215 Office E&M - Established | Office | 37 | 31 | $136.33 | $5,044 |
By year: 2022 $494K for 39,624 services; 2023 $465K for 37,573 services; 2024 $438K for 34,480 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abie A Samuel prescribed most often to Medicare patients was Prednisone, with 339 prescriptions and refills. In total Abie A Samuel wrote 1,978 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 339 | 599 | 91 | $2,181 |
| Alendronate Sodium Generic | 323 | 898 | 114 | $2,215 |
| Hydroxychloroquine Sulfate Generic | 260 | 724 | 89 | $11K |
| Methotrexate Methotrexate Sodium | 201 | 511 | 58 | $3,633 |
| Leflunomide Generic | 80 | 200 | 23 | $5,126 |
| Folic Acid Generic | 61 | 179 | 25 | $587 |
| Mycophenolate Mofetil Generic | 57 | 111 | 13 | $63K |
| Humira(Cf) Pen Adalimumab | 48 | 57 | Under 11 | $406K |
| Tramadol Hcl Generic | 42 | 52 | Under 11 | $516 |
| Enbrel Sureclick Etanercept | 41 | 50 | Under 11 | $375K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 32 | 32 | Under 11 | $863 |
| Allopurinol Generic | 31 | 89 | Under 11 | $341 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 28 | 65 | Under 11 | $294 |
| Forteo Teriparatide | 24 | 24 | Under 11 | $105K |
| Rinvoq Upadacitinib | 23 | 23 | Under 11 | $148K |
Brand drugs: 298 claims; generic drugs: 1,660 claims; opioid claims: 104.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abie A Samuel $4,098 ($4,098 in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $781.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 42 | $781 |
| Abbvie Inc. ABBV | 21 | $552 |
| Janssen Biotech, Inc. JNJ | 37 | $524 |
| UCB, Inc. UCB.BR | 17 | $376 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $357 |
| GlaxoSmithKline, LLC. GSK | 13 | $293 |
| Pfizer Inc. PFE | 11 | $239 |
| Mallinckrodt Hospital Products Inc. | 5 | $165 |
| Genzyme Corporation SNY | 6 | $160 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $152 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.